WisconsinAquaculture.com - Aquaculture Drug Update: New INAD Erymicin 200
FIND a WAA Fish Farmer FIND a FISH FARMER   My Shopping Cart MY Shopping Bag   Contact Us Contact
Aquaculture Drug Update: New INAD Erymicin 200

Aquaculture Drug Update: New INAD Erymicin 200

Authorization has been received from the U.S. Food and Drug Administration Center for Veterinary Medicine for new INAD 12-781 for the use of erythromycin (Erymicin 200 Injection) treatment to control bacterial kidney disease (BKD; causative agent Renibacterium salmoninarum) in salmonids. More specifically, Erymicin 200 Injection treatment may be used to 1) control mortality caused by BKD in salmonid species, and 2) reduce or minimize R. Salmoninarum levels in BKD positive female salmonid broodstock in order to control (prevent) the vertical transmission of R. Salmoninarum to eggs/progeny.

Bacterial kidney has long posed a serious health concern in both cultured and free-ranging salmonid populations, and we are pleased to announce this opportunity for not only a new BKD treatment option, but also for AADAP to begin cooperatively generating safety and effectiveness data that can ultimately be used to support FDA-approval of Erymicin 200 Injection for use in aquatic species. Learn more.

 

  .: More Fish Health :.  
[ Return ] to previous page.
WisconsinAquaculture.com - Aquaculture Drug Update: New INAD Erymicin 200
WisconsinAquaculture.com - Aquaculture Drug Update: New INAD Erymicin 200
Shop NOW!
WisconsinAquaculture.com - Aquaculture Drug Update: New INAD Erymicin 200
•   Events & Seminars  • Literature and Posters  • Clothing  • DVD  • WAA Membership  • Advertising  •
WisconsinAquaculture.com - Aquaculture Drug Update: New INAD Erymicin 200
 
Accepted Here
We Accept Visa
Visa
We Accept MasterCard
MasterCard
We Accept Discover
Discover
 
^ Top Of Page ^
 

 


WisconsinAquaculture.com Powered By Adobe ColdFusion